Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential Activation of mTOR Complex 1 Signaling in Human Brain with Mild to Severe Alzheimer's Disease
Yong-Xin Sun, Xunming Ji, XiaoOu Mao, et al.
Journal of Alzheimer s Disease (2013) Vol. 38, Iss. 2, pp. 437-444
Closed Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Regulation and metabolic functions of mTORC1 and mTORC2
Angelia Szwed, Eugene Kim, Estela Jacinto
Physiological Reviews (2021) Vol. 101, Iss. 3, pp. 1371-1426
Open Access | Times Cited: 484
Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Md. Sahab Uddin, Anna Stachowiak, Abdullah Al Mamun, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 365
Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy
Matteo Bordi, Martin J. Berg, Panaiyur S. Mohan, et al.
Autophagy (2016) Vol. 12, Iss. 12, pp. 2467-2483
Open Access | Times Cited: 295
mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy
Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield
Neurobiology of Disease (2015) Vol. 84, pp. 39-49
Closed Access | Times Cited: 293
Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to Function
Anne Biever, Emmanuel Valjent, Emma Puighermanal
Frontiers in Molecular Neuroscience (2015) Vol. 8
Open Access | Times Cited: 206
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Henry Querfurth, Hankyu Lee
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 189
Rapamycin and Alzheimer’s disease: Time for a clinical trial?
Matt Kaeberlein, Verónica Galván
Science Translational Medicine (2019) Vol. 11, Iss. 476
Open Access | Times Cited: 154
Novel target for treating Alzheimer’s Diseases: Crosstalk between the Nrf2 pathway and autophagy
Wei Zhang, Feng Cong, Hong Jiang
Ageing Research Reviews (2020) Vol. 65, pp. 101207-101207
Closed Access | Times Cited: 149
Impaired insulin signalling and allostatic load in Alzheimer disease
Fernanda G. De Felice, Rafaella A. Gonçalves, Sérgio T. Ferreira
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 4, pp. 215-230
Closed Access | Times Cited: 126
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
Wei Zhang, Chengchao Xu, Jichao Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 3, pp. 1019-1040
Open Access | Times Cited: 112
Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain
Marzia Perluigi, Gilda Pupo, Antonella Tramutola, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1842, Iss. 7, pp. 1144-1153
Open Access | Times Cited: 151
Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy
Sarah Gourmaud, Haochang Shou, David J. Irwin, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 191-209
Open Access | Times Cited: 119
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story
Arlan Richardson, Verónica Galván, Ai-Ling Lin, et al.
Experimental Gerontology (2014) Vol. 68, pp. 51-58
Open Access | Times Cited: 113
Milk’s Role as an Epigenetic Regulator in Health and Disease
Bodo C. Melnik, Gerd Schmitz
Diseases (2017) Vol. 5, Iss. 1, pp. 12-12
Open Access | Times Cited: 111
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics
Fabio Di Domenico, Eugenio Barone, Marzia Perluigi, et al.
Antioxidants and Redox Signaling (2016) Vol. 26, Iss. 8, pp. 364-387
Closed Access | Times Cited: 104
Nutritional strategies to optimise cognitive function in the aging brain
Devin Wahl, Victoria C. Cogger, Samantha M. Solon‐Biet, et al.
Ageing Research Reviews (2016) Vol. 31, pp. 80-92
Open Access | Times Cited: 100
Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders
Baruh Polis, AbrahamO Samson
Neural Regeneration Research (2020) Vol. 15, Iss. 8, pp. 1460-1460
Open Access | Times Cited: 95
Macroautophagy and aging: The impact of cellular recycling on health and longevity
José L. Nieto-Torres, Malene Hansen
Molecular Aspects of Medicine (2021) Vol. 82, pp. 101020-101020
Open Access | Times Cited: 61
Defective proteostasis in Alzheimer’s disease
Danielle Cozachenco, Felipe C. Ribeiro, Sérgio T. Ferreira
Ageing Research Reviews (2023) Vol. 85, pp. 101862-101862
Closed Access | Times Cited: 34
Lingguizhugan decoction enhances autophagy of Alzheimer’s disease via regulating the mTOR/ p70s6K pathway in vivo and in vitro
Xiaojing Chen, Q. Tian, Min Gao, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access | Times Cited: 1
Heavy metal-induced disruption of the autophagy-lysosomal pathway: implications for aging and neurodegenerative disorders
Suman Das, Lokesh Murumulla, Pritha Ghosh, et al.
BioMetals (2025)
Closed Access | Times Cited: 1
Could Alzheimer’s Disease Originate in the Periphery and If So How So?
Gerwyn Morris, Michael Berk, Michaël Maes, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 406-434
Open Access | Times Cited: 80
Aberrant mTOR activation in senescence and aging: A mitochondrial stress response?
Timothy Nacarelli, Ashley Azar, Christian Sell
Experimental Gerontology (2014) Vol. 68, pp. 66-70
Open Access | Times Cited: 76
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies
Antonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico
Expert Review of Neurotherapeutics (2016) Vol. 17, Iss. 1, pp. 33-45
Closed Access | Times Cited: 65
Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation
Artem P. Gureev, В. Н. Попов, Anatoly A. Starkov
Experimental Neurology (2020) Vol. 328, pp. 113285-113285
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top